Peter J. Langecker
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Peter J. Langecker
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.
22
| Subsidiary | Pharmaceuticals: Major | 22 |
| Public Company | Biotechnology | 15 | |
Xcyte Therapies, Inc.
14
| Extinct | Pharmaceuticals: Major | 14 |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics.
12
| Extinct | Pharmaceuticals: Major | 12 |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.
9
| Private Company | Biotechnology | 9 |
| Public Company | Pharmaceuticals: Major | 8 | |
Sugen, Inc.
 Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY.
7
| Extinct | Pharmaceuticals: Major | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Peter J. Langecker tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Stanford University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer Treasurer Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Chief Executive Officer Investor Relations Contact Chief Executive Officer | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Corporate Officer/Principal Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Masters Business Admin | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director of Finance/CFO | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Corporate Officer/Principal Masters Business Admin | |
| PDL BIOPHARMA, INC. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO General Counsel | |
| RELYPSA INC | Pharmaceuticals: Major | Chairman Investor Relations Contact Chief Executive Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin Doctorate Degree | |
| HUMANIGEN, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal General Counsel | |
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Founder Director/Board Member Founder | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ALZA CORPORATION | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| CYCLACEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Treasurer | |
| Boston University | College/University | Undergraduate Degree Undergraduate Degree | |
The Conference Board, Inc.
 The Conference Board, Inc. Miscellaneous Commercial ServicesCommercial Services The Conference Board, Inc. is a membership organization working for the public interests. It creates and disseminates knowledge about management and the marketplace to help businesses in their performance and to better serve the society. The firm publishes information and analysis, makes economics-based forecasts and assesses trends, and facilitates learning by creating communities of interest that bring together senior executives from around the world. The company was founded in 1916 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| New York University | College/University | Masters Business Admin Masters Business Admin | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Corporate Secretary Director of Finance/CFO | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director/Board Member | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of San Francisco | College/University | Undergraduate Degree Masters Business Admin | |
American Association of Pharmaceutical Scientists
 American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ODONATE, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| TITAN PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL. | College/University | Masters Business Admin Graduate Degree | |
| DIMENSION THERAPEUTICS INC | Biotechnology | President Director/Board Member | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Comptroller/Controller/Auditor | |
Symphony ViDA, Inc.
 Symphony ViDA, Inc. Pharmaceuticals: MajorHealth Technology Symphony ViDA, Inc. develops and manufactures biopharmaceutical drugs. Its products are used to treat the multiple forms of cancer and neovascular diseases of the eye. The company was founded in October 2008 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 50 |
| Israele | 2 |
Settori
| Health Technology | 32 |
| Consumer Services | 14 |
| Commercial Services | 6 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 438 |
| Corporate Officer/Principal | 251 |
| Independent Dir/Board Member | 114 |
| President | 82 |
| Chief Executive Officer | 70 |
Contatti più connessi
| Insiders | |
|---|---|
| Arthur Laffer | 49 |
| Jean-Francois Formela | 48 |
| Tamar Howson | 41 |
| Julie Cherrington | 32 |
| Arlene Morris | 28 |
| Michael Bigham | 27 |
| Dennis J. Henner | 26 |
| Patricia Russo | 26 |
| Dan Spiegelman | 24 |
| Bill N. Shiebler | 24 |
| Jean Deleage | 23 |
| James Robinson | 23 |
| George Tidmarsh | 22 |
| John Orwin | 21 |
| Joseph Stauffer | 21 |
- Borsa valori
- Insiders
- Peter J. Langecker
- Connessioni Società
